Effect of NF-κB inhibitor on high mobility group protein B1 expression in a COPD rat model

Molecular Medicine Reports

Volumn 7, Issue 2, 2013, Pages 499-502

  Wang, Chang Ming ^a   Jiang, Ming ^a   Wang, Hui Juan ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; High mobility group protein B1; NF B; NF B inhibitor; Pyrrolidine dithiocarbamate

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HYPOXIA; LUNG PARENCHYMA; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HMGB1 PROTEIN; LUNG; MALE; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIOCARBAMATES;

EID: 84873842631     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1181     Document Type: Article

References (20)

1. Barbera JA, Peinado VI and Santos S: Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 21: 892-905, 2003.
2. Dorfmuller P, Perros F, Balabanian K and Humbert M: Inflammation in pulmonary arterial hypertension. Eur Respir J 22: 358-363, 2003.
3. Weitzenblum E, Chaouat A, Canuet M and Kessler R: Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin Respir Crit Care Med 30: 458-470, 2009.
4. Barbera JA and Blanco I: Pulmonary hypertension in patients chronic obstructive pulmonary disease advances in pathophysiology and management. Drugs 69: 1153-1171, 2009.
5. Wang H, Yang H and Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 255: 320-331, 2004.
6. Grasser M, Lentz A, Lichota J, Merkle T and Grasser KD: The Arabidopsis genome encodes structurally and functionally diverse HMGB-type proteins. J Mol Biol 358: 654-664, 2006.
7. Ferhani N, Letuve S, Kozhich A, et al: Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181: 917-927, 2010.
8. Rabe KF, Hurd S, Anzueto A, et al: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555, 2007.
9. Wouters EF, Groenewegen KH, Dentener MA and Vernooy JH: Systemic inflammation in exacerbation of COPD. Thorac Soc 4: 626-634, 2007.
10. Gea J, Barreiro E and Orozco Levi M: Systemic inflammation in COPD. Clin Pulm Med 16: 233-242, 2009.
11. Yamada S and Maruyama I: HMGB1, a novel inflammatory cytokine. Clin Chim Acta 375: 36-42, 2007.
12. Štros M, Bačíková A, Polanská E, Štokrová J and Strauss F: HMGB1 interacts with human to poisomerase alpha and stimulates its catalytic activity. Nucleic Acids Res 35: 5001-5013, 2007.
13. Ferhani N, Letuve S, Kozhich A, et al: Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir and Crit Care Med 181: 917-927, 2010.
14. Penzo M, Molteni R, Suda T, et al: Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis. J Immunol 184: 4497-4509, 2010.
15. Palumbo R, Galvez BG, Pusterla T, et al: Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappa B activation. J Cell Biol 179: 33-40, 2007.
16. Qin YH, Dai SM, Tang GS, et al: HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J Immunol 183: 6244-6250, 2009.
17. Kew RR, Penzo M, Habiel DM and Marcu KB: The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J Immunol 188: 2380-2386, 2012.
18. Frenette PS, Mayadas TN, Rayburn H, Hynes RO and Wagner DD: Susceptibility to infection and altered hematopoiesis in mice deficient in both P and E selectin. Cell 84: 563-574, 1996.
19. Naka Y, Toda K, Kayano K, Oz MC and Pinsky DJ: Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. Proc Natl Acda Sci USA 94: 757-761, 1997.
20. Bruck R, Schey R, Aeed H, Hochman A, Genina O and Pines M: A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis. Liver Int 24: 169-176, 2004.